Все публикации

0:13:52

Ellen Border Perspective - World Cancer Research Day

1:05:11

Update on Adaptimmune's SURPASS Family of Trials

2:00:38

Adaptimmune's Symposium at CTOS 2021– “Spotlight on Synovial Sarcoma; Where are we now? Where next?”

0:53:30

REPLAY of Adaptimmune’s First Live Virtual Event – Our Allogeneic Platform

0:19:24

Adaptimmune reports updated SURPASS data at ESMO 2021

0:03:53

Dennis Williams, SVP Late Stage Development, reflects on Sarcoma Awareness Month.

0:03:39

Adaptimmune's allogeneic or 'off-the-shelf' cell therapies.

0:00:43

More colleagues take part in Wear White Day 2021

0:02:17

Adaptimmune Wear White Video 2021

0:07:44

E. Norry & D. Williams present initial data from SPEARHEAD-1 trial

0:04:23

Karen Miller, SVP Clinical Pipeline talks about the HiT Platform.

0:05:26

Adaptimmune ASGCT 2021

0:09:35

AACR Annual Virtual Meeting 2021 - Focus on our SURPASS and ADP-A2AFP trials

0:40:18

Adaptimmune Presentation at 39th Annual J.P. Morgan Healthcare Conference

0:03:48

Manufacturing at Adaptimmune

0:03:22

Our Research: A Rich Cell Therapy Pipeline for the Future

0:08:42

SITC 2020 - Adaptimmune's SURPASS Poster

0:02:21

SPEARHEAD-2 trial design: combining SPEAR T-cells with pembrolizumab

0:02:17

Mecanismo de Acción del ADP-A2M4CD8 (SPEAR-T cell de próxima generación)

0:07:48

ADP-A2AFP data presented at the 2020 International Liver Congress

0:01:11

Adaptimmune supports the CRI's Wear White Day 2020

0:01:32

ADP-A2M4CD8 Mechanism of Action (Next-generation SPEAR T-cell)

0:13:30

SPEAR T-cells Derived from Stem Cells Kill Cancer Targets in vitro - data from ASGCT 2020

0:01:00

Medical Need for People with Synovial Sarcoma